The Patent Finder

Particle Formation And Morphology

Halozyme Hypercon, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/US2020/015957, filed Jan 30, 2020. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,717,488Particle Formation And Morphology
In force
 · Low confidence
Halozyme Hypercon, Inc.In force
Low confidence
US 12,558,323Particle Formation And Morphology
In force
 · Low confidence
Halozyme Hypercon, Inc.In force
Low confidence
Application 18/344,142Particle Formation And Morphology
Pending
Not granted
Halozyme Hypercon, Inc.PendingNot granted
Application 18/907,018Methods of Producing Particles Comprising a Therapeutic Biologic
Pending
Not granted
Halozyme Hypercon, Inc.PendingNot granted
Application 19/453,546Particle Formation And Morphology
Pending
Not granted
Halozyme Hypercon, Inc.PendingNot granted
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Halozyme Hypercon, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited